AN
CelLBxHealth plc
ANPCY · OTC
$0.07 +0.00% (+$0.00)
Market Cap £1.63M
P/E Ratio -
Div. Yield -
ROE 104.73%
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.62x
P/B 0.14x
P/E N/A
Growth
61 /100
Stable Rev. growth 6.10%
Book val. growth 14.63%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 62.27%
Net margin 601.37%
FCF margin 442.84%
Quality
2 /100
Poor ROIC 105.60%
ROE 104.73%
Asset turnover 0.15x
Debt
80 /100
Low Debt/Equity 0.31x
Current ratio 3.13x
Net debt/EBITDA 0.10x
Stability
42 /100
Moderate Beta 0.14x
Rev. volatility 23.15%
Profitable years 0
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o ANPCY
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Peter Collins
Employees
119
Headquarters
Guildford